Urinary Tract Infection Therapeutics: By Indication (Complicated UTI, Uncomplicated UTI and Other), By Drug Type (Quinolones, Cephalosporin, Azoles and Amphotericin B, Nitro furans and Other) And Region - Global Analysis of Market Size, Share & Trends for 2019-2020 And Forecasts to 2031
1 Executive Summary
1.1. Regional Market Share
1.2. Business Trends
1.3. Global Urinary Tract Infection Therapeutics Market: COVID-19 Outbreak
1.4. Regional Trends
1.5. Segmentation Snapshot
2 Research Methodology
2.1. Research Objective
2.2. Research Approach
2.3. Data Sourcing and Methodology
2.4. Primary Research
2.5. Secondary Research
2.5.1. Paid Sources
2.5.2. Public Sources
2.6. Market Size Estimation and Data Triangulation
3 Market Characteristics
3.1. Market Definition
3.2. Global Urinary Tract Infection Therapeutics Market: COVID-19 Impact
3.3. Key Segmentations
3.4. Key Developments
3.5. Allied Industry Data
4 Global Urinary Tract Infection Therapeutics Market – Industry Insights
4.1. Industry Segmentation
4.2. COVID-19 overview on world economy
4.3. Industry ecosystem Channel analysis
4.4. Innovation & Sustainability
5 Macroeconomic Indicators
6 Recent Developments
7 Market Dynamics
7.1. Introduction
7.2. Growth Drivers
7.3. Market Opportunities
7.4. Market Restraints
7.5. Market Trends
8 Risk Analysis
9 Market Analysis
9.1. Porters Five Forces
9.2. PEST Analysis
9.2.1. Political
9.2.2. Economic
9.2.3. Social
9.2.4. Technological
10 Global Urinary Tract Infection Therapeutics Market
10.1. Overview
10.2. Historical Analysis (2016-2020)
10.2.1. Market Size, Y-o-Y Growth (%) and Market Forecast
11 Global Urinary Tract Infection Therapeutics Market Size & Forecast 2021A-2031F
11.1. Overview
11.2. Key Findings
11.3. Market Segmentation
11.3.1. By Indication
11.3.1.1. Complicated UTI
11.3.1.1.1. By Value (USD Million) 2021-2031F
11.3.1.1.2. Market Share (%) 2021-2031F
11.3.1.1.3. Y-o-Y Growth (%) 2021-2031F
11.3.1.2. Uncomplicated UTI
11.3.1.2.1. By Value (USD Million) 2021-2031F
11.3.1.2.2. Market Share (%) 2021-2031F
11.3.1.2.3. Y-o-Y Growth (%) 2021-2031F
11.3.1.3. Other
11.3.1.3.1. By Value (USD Million) 2021-2031F
11.3.1.3.2. Market Share (%) 2021-2031F
11.3.1.3.3. Y-o-Y Growth (%) 2021-2031F
11.3.2. By Drug Type
11.3.2.1. Quinolones
11.3.2.1.1. By Value (USD Million) 2021-2031F
11.3.2.1.2. Market Share (%) 2021-2031F
11.3.2.1.3. Y-o-Y Growth (%) 2021-2031F
11.3.2.2. Cephalosporin
11.3.2.2.1. By Value (USD Million) 2021-2031F
11.3.2.2.2. Market Share (%) 2021-2031F
11.3.2.2.3. Y-o-Y Growth (%) 2021-2031F
11.3.2.3. Azoles and Amphotericin B
11.3.2.3.1. By Value (USD Million) 2021-2031F
11.3.2.3.2. Market Share (%) 2021-2031F
11.3.2.3.3. Y-o-Y Growth (%) 2021-2031F
11.3.2.4. Nitro furans
11.3.2.4.1. By Value (USD Million) 2021-2031F
11.3.2.4.2. Market Share (%) 2021-2031F
11.3.2.4.3. Y-o-Y Growth (%) 2021-2031F
11.3.2.5. Other
11.3.2.5.1. By Value (USD Million) 2021-2031F
11.3.2.5.2. Market Share (%) 2021-2031F
11.3.2.5.3. Y-o-Y Growth (%) 2021-2031F
12 North America Urinary Tract Infection Therapeutics Market Size & Forecast 2021A-2031F
12.1. Overview
12.2. Key Findings
12.3. Market Segmentation
12.3.1. By Indication
12.3.2. By Drug Type
12.4. Country
12.4.1. United States
12.4.2. Canada
13 Europe Urinary Tract Infection Therapeutics Market Size & Forecast 2021A-2031F
13.1. Overview
13.2. Key Findings
13.3. Market Segmentation
13.3.1. Indication
13.3.2. By Drug Type
13.4. Country
13.4.1. Germany
13.4.2. United Kingdom
13.4.3. France
13.4.4. Italy
13.4.5. Spain
13.4.6. Russia
13.4.7. Rest of Europe (BENELUX, NORDIC, Hungary, Turkey & Poland)
14 Asia Urinary Tract Infection Therapeutics Market Size & Forecast 2021A-2031F
14.1. Overview
14.2. Key Findings
14.3. Market Segmentation
14.3.1. By Indication
14.3.2. By Drug Type
14.4. Country
14.4.1. India
14.4.2. China
14.4.3. South Korea
14.4.4. Japan
14.4.5. Rest of APAC
15 Middle East and Africa Urinary Tract Infection Therapeutics Market Size & Forecast 2021A-2031F
15.1. Overview
15.2. Key Findings
15.3. Market Segmentation
15.3.1. By Indication
15.3.2. By Drug Type
15.4. Country
15.4.1. Israel
15.4.2. GCC
15.4.3. North Africa
15.4.4. South Africa
15.4.5. Rest of Middle East and Africa
16 Latin America Urinary Tract Infection Therapeutics Market Size & Forecast 2021A-2031F
16.1. Overview
16.2. Key Findings
16.3. Market Segmentation
16.3.1. By Indication
16.3.2. By Drug Type
16.4. Country
16.4.1. Mexico
16.4.2. Brazil
16.4.3. Rest of Latin America
17 Competitive Landscape
17.1. Company market share, 2021
17.2. Key player overview
17.3. Key stakeholders
18 Company Profiles
18.1. Allergan
18.1.1. Company Overview
18.1.2. Financial Overview
18.1.3. Key Product; Analysis
18.1.4. Company Assessment
18.1.4.1. Product Portfolio
18.1.4.2. Key Clients
18.1.4.3. Market Share
18.1.4.4. Recent News & Development (Last 3 Yrs.)
18.1.4.5. Executive Team
18.2. Bayer AG
18.3. Pfizer, Inc.
18.4. GlaxoSmithKline plc
18.5. Bristol-Myers Squibb Company
18.6. Janssen Global Services, LLC
18.7. Lupin Ltd.
18.8. Merck & Co., Inc
18.9. Almirall, S.A
18.10. Other Prominent Players
19 Appendix
20 Consultant Recommendation
Select License Type
Select License Type